{"id":"NCT02189837","sponsor":"Amgen","briefTitle":"Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody","officialTitle":"Double-blind, Randomized, Placebo-controlled, Single Site Study to Evaluate the Effects of Evolocumab (AMG 145) Treatment, Alone and in Combination With Atorvastatin, on Lipoprotein Kinetics","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-07-08","primaryCompletion":"2015-02-13","completion":"2015-03-05","firstPosted":"2014-07-15","resultsPosted":"2016-08-31","lastUpdate":"2018-10-03"},"enrollment":89,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Primary Hyperlipidemia and Mixed Dyslipidemia"],"interventions":[{"type":"BIOLOGICAL","name":"Evolocumab","otherNames":["AMG 145","Repatha"]},{"type":"DRUG","name":"Atorvastatin","otherNames":["LIPITORÂ®"]},{"type":"DRUG","name":"Placebo to Evolocumab","otherNames":[]},{"type":"DRUG","name":"Placebo to Atorvastatin","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Atorvastatin","type":"ACTIVE_COMPARATOR"},{"label":"Evolocumab","type":"EXPERIMENTAL"},{"label":"Evolocumab and Atorvastatin","type":"EXPERIMENTAL"}],"summary":"This is a randomized, double-blind, placebo-controlled trial to evaluate the effect of evolocumab, atorvastatin, and combination therapy on lipoprotein kinetics.","primaryOutcome":{"measure":"Percent Change From Baseline in Low-density Lipoprotein (LDL) Apolipoprotein B-100 Fractional Catabolic Rate (FCR)","timeFrame":"Baseline (5 days prior to Day 1) and Day 50; plasma samples for fasting lipids were obtained at 0, 5, 10, 20, 30, 40, and 60 min, as well as at 1.5, 2, 2.5, 3, 4, 5, 6, 8, and 10 hours, and 2, 3, 4 and 5 days after D3-leucine administration.","effectByArm":[{"arm":"Placebo","deltaMin":-5.07,"sd":26.06},{"arm":"Atorvastatin","deltaMin":74.13,"sd":24.84},{"arm":"Evolocumab","deltaMin":83.7,"sd":26.06},{"arm":"Evolocumab and Atorvastatin","deltaMin":310.48,"sd":26.68}],"pValues":[{"comp":"OG000 vs OG002","p":"0.018"},{"comp":"OG001 vs OG003","p":"<0.001"},{"comp":"OG000 vs OG001 vs OG002 vs OG003","p":"0.005"}]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":true,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":2,"countries":["Australia"]},"refs":{"pmids":["27941065","29566128","29880491","30897995"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":21},"commonTop":["Headache","Nausea","Nasopharyngitis","Myalgia","Abdominal pain"]}}